Yüklüyor......
Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
Low-dose naltrexone is a widely used off-label therapeutic prescribed for a variety of immune-related disorders. The mechanism underlying low-dose naltrexone’s efficacy for fatigue, Crohn’s disease, fibromyalgia, and multiple sclerosis is, in part, intermittent blockade of opioid receptors followed...
Kaydedildi:
| Yayımlandı: | Exp Biol Med (Maywood) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648293/ https://ncbi.nlm.nih.gov/pubmed/28766982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217724791 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|